Biologics targeting interleukin (IL)-12, IL-23, and IL-17 may have valuable safety benefits among older adults with psoriatic disease, as a lower rate of serious infection was observed among these ...

Multiple measures of patient satisfaction and quality of life improved up to 1 year following Mohs micrographic surgery for facial skin cancer.

Icotrokinra appears to be an effective treatment for adolescents with moderate to severe plaque psoriasis, according to a subgroup analysis of the ICONIC-LEAD study.

Environmental surfaces and health care personnel hands may serve as "reservoirs" for infectious disease transmission between patients.

The FDA will begin promoting computer-based and lab-grown drug testing models to reduce the cost, time, and ethical burden of drug testing.